|
|
|
|
|
|
Infinity Pharmaceuti (INFI)
|
|
1.81 -0.20 (-9.95%)
|
6/23/2017 4:00pm
|
|
Open:
|
2.00
|
Pre. Close:
|
2.01
|
|
High:
|
2.02
|
Low:
|
1.80
|
|
Volume:
|
5,366,106
|
Market Cap:
|
91.30M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.03 - 2.07
|
2.07 - 2.11
|
|
Low:
|
1.71 - 1.74
|
1.74 - 1.78
|
|
Close:
|
1.77 - 1.83
|
1.83 - 1.89
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-23 4:35:37 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 2.29 One year: 2.51
|
|
Support:
|
Support1: 1.65 Support2: 1.37
|
|
Resistance:
|
Resistance1:
1.96 Resistance2: 2.15
|
|
Pivot:
|
1.83 
|
|
Moving Averages:
|
MA(5): 1.93 MA(20): 1.81
MA(100): 2.32 MA(250): 1.80
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9): -0.03
|
|
%K %D:
|
%K(14,3): 61.50 %D(3): 71.09
|
|
RSI:
|
RSI(14): 47.97
|
|
52-Week:
|
High: 3.84
Low: 0.84 Change(%): 40.4
|
|
Average Vol(K):
|
3-Month: 53481
10-Days 853
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.INFI has closed above bottom band by 48.9%. Bollinger Bands are 53.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to INFI's normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Tue, 14 Jun 2016 16:45:29 GMT
Why Infinity Pharmaceuticals Inc. Is Being Obliterated Today
Wed, 25 Jan 2017 19:07:30 GMT
Infinity Pharma Surges On Latest Cancer Drug Hope
Wed, 10 May 2017 02:03:45 GMT
Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q1 2017 Results ...
Mon, 13 Feb 2017 13:30:00 GMT
Infinity Announces Promotion of Jeffery Kutok, MD, Ph.D. to Chief Scientific ...
Thu, 02 Mar 2017 13:30:00 GMT
Infinity Announces Presentation on IPI-549 at AACR Annual Meeting
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
